KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The public health emergency has prompted international health agencies, including the World Health Organization, to support local medical teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
Health Ministry Focuses on Delivering Ervebo Doses to Medical Professionals in Kisangani
Operational challenges hinder logistics due to complex regional infrastructure, persistent security issues, and high population movement across border districts. Cold-chain networks have been established in Kisangani to ensure the vaccines are kept at the required ultra-low temperatures before reaching outlying health zones. DR Congo initiates Ebola vaccination efforts while civil defense and community health workers conduct outreach to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention collaborate closely with local teams to monitor adverse events and assess immune responses among vaccinated groups. Officials highlighted that early detection, combined with isolation procedures and supportive treatment, remains critical to increasing patient survival rates. Additional vaccine consignments are planned to support regional distribution expansion across secondary health districts.
Government Enforces Rigorous Infection Control Procedures at Treatment Facilities
National teams continue expanding contact-tracing operations throughout urban and rural areas of the eastern region. Health centers are supplied with personal protective equipment, diagnostic reagents, and treatment supplies to bolster readiness. Officials confirmed that public health measures will stay in effect until data shows a consistent decline in transmission rates across all affected provinces.
The government urged local communities to fully cooperate with mobile vaccination efforts and follow established health guidelines. It is anticipated that increasing immunization among high-risk populations will help stabilize infection levels over the coming weeks. Surveillance networks will keep heightened monitoring at transportation hubs and border crossings to prevent further spread geographically.